Phibro Animal Health
NasdaqGM:PAHC Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
AN
Consensus Narrative from 5 Analysts
Zoetis MFA Portfolio Integration Will Expand Domestic And International Demand
Key Takeaways Successful integration of Zoetis MFA portfolio and Phibro Forward initiative are expected to drive revenue growth and improve margins through operational excellence. Strategic innovation and portfolio expansion anticipated to significantly enhance earnings despite challenges in the protein industry.
View narrativeUS$21.00
FV
4.3% overvalued intrinsic discount12.43%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
3 days ago author updated this narrative